MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR). (12th June 2019)

• Record Type: Journal Article
• Authors: Hill, B.T.; Switchenko, J.M.; Martin, P.; Churnetski, M.C.; Sawalha, Y.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.N.; Barta, S.K.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.S.; Mathews, S.; Burkart, M.; Karmali, R.; Ghosh, N.; Park, S.I.; Epperla, N.; Bond, D.A.; Badar, T.; Blum, K.A.; Guo, J.; Hamadani, M.; Fenske, T.S.; Malecek, M.; Maddocks, K.; Flowers, C.R.; Kahl, B.S.; Cohen, J.B.;
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 405
• Page End: 407
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.75_2631
• Languages: English
• ISSNs: 0278-0232